Green Alpha Advisors, LLC 2seventy Bio, Inc. Transaction History

Green Alpha Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	BUY	$8.45 - $12.48 $13,621 - $20,117	1,612 Added 13.19%	13,837 $140,000
Q1 2023 Apr 06, 2023	SELL	$9.21 - $14.98 $2,514 - $4,089	-273 Reduced 2.18%	12,225 $124,000
Q4 2022 Jan 12, 2023	SELL	$8.57 - $17.0 $951 - $1,887	-111 Reduced 0.88%	12,498 $0
Q3 2022 Oct 14, 2022	BUY	$12.56 - $17.54 $1,256 - $1,754	100 Added 0.8%	12,609 $183,000
Q2 2022 Jul 08, 2022	BUY	$10.55 - $18.81 $131,969 - $235,294	12,509 New	12,509 $165,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.